Gamgee
YC S26 ↗Tampa, US · Founded 2026 · 2 employees · 1 known investors
GAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.
AI & Machine LearningBiotechDeep TechHealthtechArtificial IntelligenceGenomicsOncologyin /109672135@paul_conynghamycombinator.com ↗
Founders & leadership· Y Combinator alumni (S26)
PC
Paul Conynghamin𝕏Founder